Wednesday, February 10, 2010, 5:11am EST - Canadian Markets open in 4 hours and 19 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Teva Pharmaceutical Industries Ltd. (TEVA)

On Feb 9: 57.10 USD   0.00 (0.00%)  
MORE ON TEVA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Teva Pharmaceutical Industries (NasdaqNM:TEVA) Delayed quote dataEdit
Last Trade: 57.10 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 57.10
Open: N/A
Bid: 56.63 x 1000
Ask: 57.54 x 1000
1y Target Est: 51.79
Day's Range: N/A - N/A
52wk Range: 42.00 - 59.62
Volume: 0
Avg Vol (3m): 4,959,040
Market Cap: 50.31B
P/E (ttm): 25.92
EPS (ttm): 2.20
Div & Yield: 0.61 (1.06%)
Teva Pharmaceutical Industries Ltd. (TEVA)
1d  5d  3m  6m  1y  2y  5y  max 
 Add TEVA to Portfolio   Download Data

HEADLINES
[video] Stock Wrap: The Real Story, February 9
at TheStreet.com (Tue 4:52pm)
AstraZeneca Goes to the Well One Last Time
at Minyanville.com (Tue 12:50pm)
The New Danger for Foreign Investors?
at Motley Fool (Tue 11:22am)
Five Growth Stocks With a Margin of Safety
at TheStreet.com (Tue 5:00am)
Teva gets Nordic and Baltic rights for MS drug from Active Biotech
at bizjournals.com (Mon, Feb 8)
Teva, Active extend pact on oral MS therapy
at MarketWatch (Mon, Feb 8)
Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
Business Wire (Mon, Feb 8)
Teva Settles Lawsuits for $315 Million
at Fox Business (Fri, Feb 5)
[$$] Teva Reaches Preliminary Settlement In Drug Pricing Suit
at The Wall Street Journal Online (Fri, Feb 5)
Emerging-Market ETFs Still Have Steam
at TheStreet.com (Fri, Feb 5)
More Headlines for TEVA...

ANALYST
EPS Est (next year) (Dec-07) : 2.35
EPS Est (in 2 years) (Dec-08) : 2.69
Avg Rec (current)*: 2.1
PEG Ratio: 1.19
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Teva Pharmaceutical Industries Limited engages in the development, manufacture, and marketing of generic and human pharmaceuticals, active pharmaceutical ingredients (APIs), and animal health pharmaceutical products.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices